Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
YY Inc. (YY) Estimates Raised at Maxim Group Amid Solid Q1 Results, Q2 Guidance
-
American Capital Agency (AGNC) Prices 7M Offering at $25/sh
-
Maxim Group Downgrades Madison Square Garden (MSG) to Hold
-
Maxim Group Downgrades Southwestern Energy (SWN) to Hold
-
Youku.com (YOKU) PT Cut at Maxim Group, 'Sell' Maintained
-
Notable Analyst Rating Changes 04/30: (DDD) (CERN) (CMP) Upgraded; (COH) (TEVA) (CCJ) Downgraded
-
Maxim Group Downgrades Teva Pharma (TEVA) to Hold
-
Maxim Group Maintains Bullish Outlook in Athersys (ATHX) Despite Trial Failure and Massive Sell-Off
-
ECM Energy Services, Inc. Files Registration Statement for Proposed Initial Public Offering of Common Stock
-
Maxim Group Starts RRSat Global Communications Network Ltd. (RRST) at Buy
-
Gilead Sciences (GILD) Target Price Lifted at Maxim Group on Sovaldi and STR Outlook
-
Maxim Group Starts BioLineRx (BLRX) at Buy; Sees a Double
-
Unusual 11 Mid-Day Movers 04/24: (KOOL) (SGYP) (MPET) Higher; (HEAR) (CLFD) (SILC) Lower
-
Notable Analyst Rating Changes 04/24: (AAPL) (TQNT) (GT) Upgraded; (XLNX) (CLB) (FR) Downgraded
-
Maxim Group Starts Cesca Therapeutics (KOOL) at Buy; Sees Aggressive Upside
-
Maxim Group Starts YY Inc, (YY) at Buy
-
Maxim Group Upgrades Illumina (ILMN) to Buy
-
Medley Capital Corp. (MCC) Prices 6M Shares Offering at $13.25/Sh
-
Baidu (BIDU) Q1 Likely to Show Continue Revenue Acceleration - Maxim Group
-
Maxim Group Starts Galmed Pharmaceuticals (GLMD) at Buy, Sees Significant Upside
-
Maxim Group Starts Ralph Lauren (RL) at Buy
-
Notable Analyst Rating Changes 04/17: (SCTY) (NFLX) (GOGO) Upgraded; (HBAN) (SO) (MDCO) Downgraded
-
Maxim Group Starts Magnum Hunter (MHR) at Hold
-
Maxim Group Upgrades Pandora (P) to Buy
-
Orchid Island Capital Announces Closing of Sale of Shares Pursuant to Full Exercise of Underwriters' Overallotment Option
-
Box Ships (TEU) Prices 5M Offering at $2.05/Unit
-
Box Ships (TEU) Commences Offering of Stock an Warrants
-
Maxim Remains Positive on Gilead (GILD); Sovaldi is Compelling HCV Treatment from Cost-Benefit Perspective
-
PlacementTracker Publishes First Quarter 2014 PIPE Market League Tables
-
UPDATE: Maxim Cuts Genco Shipping (GNK) to Sell, Price Target Slashed to $0.25
-
Liberty Media's Sale of Majority Barnes & Noble (BKS) Stake Presents Other Opportunities, Maxim Group Says
-
Del Mar Pharma (DMPI) Started at Buy at Maxim Group
-
Pre-Open Stock Movers 4/2: (MNKD) (ENVI) (XLRN) Higher; (AGEN) (LQDT) (AGU) Lower (more...)
-
New York Mortgage Trust (NYMT) Prices 13M Offering at $7.59/Share
-
IsoRay (ISR) PT Raised to $3.50 at Maxim
-
Maxim Group Starts Profire Energy (PFIE) at Buy
-
New Study Suggests Additional Upside for Harvard Apparatus (HART), Maxim Says
-
IsoRay (ISR) Closes 5.64M Common Offeing; Sees Net Proceeds of $13.8M
-
Arlington Asset Investment (AI) Prices 2.75M Offering at $27.40/Share
-
Orchid Island Capital Closes Public Offering of Common Stock
-
Pre-Open Stock Movers 3/24: (NUS) (MVIS) (HLF) Higher; (NBR) (NTAP) (WLT) Lower (more...)
-
Agenus (AGEN) Target Cut at Maxim Group; 'Buy' Maintained
-
Organovo Holdings (ONVO) Will Present at 2nd Annual Regen Med Investor Day
-
Maxim Group Upgrades Achillion Pharmaceuticals (ACHN) to Buy
-
IsoRay (ISR) Prices Offering at $2.60/Sh
-
Maxim Group Maintains Bullish Thesis on Galena Biopharma (GALE) Despite SEC Investigation
-
Maxim Group Doubles Price Target on Synthetic Biologics (SYN)
-
Aastrom Biosciences to Present at the 2014 Regen Med Investor Day
-
Orchid Island Capital (ORC) Prices 3.2M Offering at $12.55/Share
-
Orchid Island Capital Prices Public Offering of Common Stock

